As China's population ages,the incidence of chronic diseases and cancer among the elderly is increasing. Elderly patients with chronic diseases and cancer at the end of life face significant economic pressure,and their urgent need for hospice care service should be valued by the society. Medications used in hospice care play a crucial role to meet the needs of dignity and quality of life during the terminal stage. While the study of hospice drugs started early in Western countries,China has also been paying increasing attention to it in recent years. This paper explores the issues of prescription management and new drug development in hospice care from the standpoint of pharmaceutical science and its applications. By investigating the development status of hospice care,the types of hospice drugs,and the policies related to drug research and development,we discuss how to adjust the selection of drugs for patients in hospice care to better serve them. Examples of hospice drugs from both ancient and modern times are presented,indicating that traditional Chinese medicine and original Chinese drugs with minimal side effects can play a significant role in hospice care. By learning from the successful experience of Western medicine,developing original Chinese medications specifically for the treatment of critical illnesses,innovating the management mechanism,and promoting the Chinese approach of hospice medicine research,we can establish important new paradigms for new drug development in China. These efforts are expected to promote the healthy and sustainable development of China's hospice care industry.
hospice carepalliation therapytraditional Chinese medicinenew druginstitutional innovation
万方数据
维普
